Grade 2 (G2) tumors lie between these thresholds, while poorly differentiated tumors with high mitotic activity and Ki‐67 levels are categorized as neuroendocrine carcinomas (NECs) [13]. The gene discussed is MKI67; the disease is neuroendocrine carcinoma.